- Home
- OMCL
as of 03-17-2026 3:56pm EST
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
| Founded: | 1992 | Country: | United States |
| Employees: | N/A | City: | FORT WORTH |
| Market Cap: | 1.8B | IPO Year: | 2000 |
| Target Price: | $51.14 | AVG Volume (30 days): | 528.7K |
| Analyst Decision: | Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.04 | EPS Growth: | -85.19 |
| 52 Week Low/High: | $22.66 - $51.84 | Next Earning Date: | 05-07-2026 |
| Revenue: | $787,309,000 | Revenue Growth: | 9.93% |
| Revenue Growth (this year): | 6.77% | Revenue Growth (next year): | 5.22% |
| P/E Ratio: | 876.50 | Index: | N/A |
| Free Cash Flow: | 86.9M | FCF Growth: | -44.16% |
AI-Powered OMCL Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Omnicell Inc. ($0.001 par value) (OMCL)
EVP&CHIEF LEGAL/ADMIN OFFICER
Avg Cost/Share
$34.69
Shares
7,405
Total Value
$256,879.45
Owned After
96,717.339
SEC Form 4
EVP&CHIEF LEGAL/ADMIN OFFICER
Avg Cost/Share
$36.59
Shares
4,243
Total Value
$155,251.37
Owned After
96,717.339
SEC Form 4
EVP&CHIEF LEGAL/ADMIN OFFICER
Avg Cost/Share
$49.90
Shares
6,106
Total Value
$304,689.40
Owned After
96,717.339
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Manley Corey J | OMCL | EVP&CHIEF LEGAL/ADMIN OFFICER | Mar 16, 2026 | Sell | $34.69 | 7,405 | $256,879.45 | 96,717.339 | |
| Manley Corey J | OMCL | EVP&CHIEF LEGAL/ADMIN OFFICER | Feb 17, 2026 | Sell | $36.59 | 4,243 | $155,251.37 | 96,717.339 | |
| Manley Corey J | OMCL | EVP&CHIEF LEGAL/ADMIN OFFICER | Jan 8, 2026 | Sell | $49.90 | 6,106 | $304,689.40 | 96,717.339 |
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K BUY Feb 5, 2026 · 100% conf.
Q4 2025 Earnings
8-K BUYFeb 5, 2026 · 100% conf.
1D
+3.95%
$40.62
Act: -5.14%
5D
+7.82%
$42.14
Act: -7.42%
20D
+13.10%
$44.20
Act: +5.53%
omcl-202602050000926326false00009263262026-02-052026-02-05
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): February 5, 2026
OMNICELL, INC.
(Exact name of registrant as specified in its charter)
Delaware000-3304394-3166458 (State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification Number)
4220 North Freeway Fort Worth, TX 76137 (Address of principal executive offices, including zip code)
(877) 415-9990 (Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading SymbolName of each exchange on which registered Common Stock, $0.001 par valueOMCLNASDAQ Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition. On February 5, 2026, Omnicell, Inc. (the “Company”) issued a press release announcing its financial results for the quarter and year ended December 31, 2025. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information contained in Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto are being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing. Item 9.01 Financial Statements and Exhibits. (d) Exhibits
Exhibit NumberExhibit Description 99.1Press release entitled “Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results” dated February 5, 2026
104Cover Page Interactive Data File (embedded within the inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
OMNICELL, INC.
Date: February 5, 2026 /s/ H. Baird Radford, III Baird Radford Executive Vice President and Chief Financial Officer
2025 Q3 Q3 2025 Earnings
8-K Oct 30, 2025
Q3 2025 Earnings
8-KOct 30, 2025
omcl-202510300000926326false00009263262025-10-302025-10-30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): October 30, 2025
OMNICELL, INC.
(Exact name of registrant as specified in its charter)
Delaware000-3304394-3166458 (State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification Number)
4220 North Freeway Fort Worth, TX 76137 (Address of principal executive offices, including zip code)
(877) 415-9990 (Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered Common Stock, $0.001 par valueOMCLNASDAQ Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition. On October 30, 2025, Omnicell, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended September 30, 2025 and updating its guidance for the full year 2025. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information contained in Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto are being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing. Item 9.01 Financial Statements and Exhibits. (d) Exhibits.
Exhibit NumberExhibit Description 99.1Press release entitled “Omnicell Announces Third Quarter 2025 Financial Results” dated October 30, 2025
104Cover Page Interactive Data File (embedded within the inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
OMNICELL, INC.
Date: October 30, 2025 /s/ H. Baird Radford, III Baird Radford Executive Vice President and Chief Financial Officer
2025 Q2 Q2 2025 Earnings
8-K Jul 31, 2025
Q2 2025 Earnings
8-KJul 31, 2025
omcl-202507310000926326false00009263262025-07-312025-07-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): July 31, 2025
OMNICELL, INC.
(Exact name of registrant as specified in its charter)
Delaware000-3304394-3166458 (State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification Number)
4220 North Freeway Fort Worth, TX 76137 (Address of principal executive offices, including zip code)
(877) 415-9990 (Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered Common Stock, $0.001 par valueOMCLNASDAQ Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition. On July 31, 2025, Omnicell, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended June 30, 2025 and updating its guidance for the full year 2025. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information contained in Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto are being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing. Item 9.01 Financial Statements and Exhibits. (d) Exhibits.
Exhibit NumberExhibit Description 99.1Press release entitled “Omnicell Announces Second Quarter 2025 Results” dated July 31, 2025
104Cover Page Interactive Data File (embedded within the inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
OMNICELL, INC.
Date: July 31, 2025 /s/ Nchacha E. Etta Nchacha E. Etta Executive Vice President and Chief Financial Officer
Compare OMCL vs Leading Stocks
See how OMCL stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "OMCL Omnicell Inc. ($0.001 par value) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.